First Time Loading...

Mirati Therapeutics Inc
NASDAQ:MRTX

Watchlist Manager
Mirati Therapeutics Inc Logo
Mirati Therapeutics Inc
NASDAQ:MRTX
Watchlist
Price: 58.7 USD Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

MRTX Price Targets Summary
Mirati Therapeutics Inc

Wall Street analysts forecast MRTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRTX is 64.5 USD .

MRTX Lowest Forecast
Wall Street Target
Not Available
MRTX Average Forecast
Wall Street Target
64.5 USD
10% Upside
MRTX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
64.5 USD
10% Upside
Highest
Price Target
Not Available
Mirati Therapeutics Inc Competitors:
Price Targets
PRLD
Prelude Therapeutics Inc
45% Upside
N
4893
Noile-Immune Biotech Inc
159% Upside
688363
Bloomage Biotechnology Corp Ltd
60% Upside
BVXP
Bioventix PLC
36% Upside
PRLD
Prelude Therapeutics Inc
45% Upside
N
4893
Noile-Immune Biotech Inc
159% Upside
688363
Bloomage Biotechnology Corp Ltd
60% Upside
BVXP
Bioventix PLC
36% Upside
PTCT
PTC Therapeutics Inc
5% Downside
CUV
Clinuvel Pharmaceuticals Ltd
76% Upside
KYMR
Kymera Therapeutics Inc
53% Upside
KOD
Kodiak Sciences Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Mirati Therapeutics Inc

The compound annual growth rate of Mirati Therapeutics Inc's revenue for the next 4 years is 152%.

N/A
Past Growth
152%
Estimated Growth
Estimates Accuracy
8%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Mirati Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
59%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Mirati Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
What are analyst estimates?

See Also

Summary
MRTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRTX stock valuation using valuation multiples.
Wall Street Estimates
MRTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRTX's stock price target?
Price Target
64.5 USD

According to Wall Street analysts, the average 1-year price target for MRTX is 64.5 USD .

What is Mirati Therapeutics Inc's Revenue forecast?
Projected CAGR
152%

The compound annual growth rate of Mirati Therapeutics Inc's revenue for the next 4 years is 152%.

ALPHA SPREAD
Join more than 132,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.